Orbimed Advisors LLC
Director10% Owner

Orbimed Advisors LLC insider trades: Electra Therapeutics (ETRA) stock buys and sales

Director, Electra Therapeutics Last trade Nov 5, 2026 434 Form 4 filings
$106.5M
Sold, last 12 months
12 sales
$130.7M
Bought, last 12 months
9 buys
371
Open-market trades
since 2005
111
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Orbimed Advisors LLC reports to the SEC

and 105 more companies

Open-market buys and sales

371 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 5, 2026ETRA↑ Buy$3.6M
Nov 2, 2026ASPE↑ Buy$15.0M
Sep 28, 2026ADRX↑ Buy$16.1M
Sep 21, 2026ETRA↑ Buy$20.0M
Aug 10, 2026BLSM↑ Buy$10.0M
Aug 7, 2026BRVE↑ Buy$34.9M
Jul 27, 2026SCTX↑ Buy$15.0M
Jul 7, 2026SION↓ Sell10b5-1$3.9M
Jun 30, 2026SION↓ Sell10b5-1$5.3M
Jun 22, 2026ELVN↓ Sell$39.0M
Jun 15, 2026ELVN↓ Sell$12.7M
May 28, 2026QTTB↑ Buy$15.0M
May 27, 2026SION↓ Sell10b5-1$4K
May 11, 2026SION↓ Sell10b5-1$13.4M
Apr 18, 2026SION↓ Sell10b5-1$2.5M
Apr 16, 2026TRAW↑ Buy$998K
Apr 16, 2026SION↓ Sell10b5-1$22.9M
Apr 8, 2026ACET↓ Sell$675K
Feb 3, 2026SION↓ Sell$1.4M
Dec 19, 2025SION↓ Sell$83K
Nov 26, 2025SION↓ Sell$4.8M
Oct 23, 2025PMVP↓ Sell$1.5M
Oct 8, 2025ACET↑ Buy$5.0M
Sep 10, 2025PMVP↓ Sell$900K
Aug 25, 2025STTK↑ Buy$5.5M
Jun 27, 2025CRVS↓ Sell$4.9M
Jun 26, 2025PASG↓ Sell$197K
May 14, 2025NPCE↓ Sell$2.7M
Apr 24, 2025PASG↓ Sell$79K
Apr 17, 2025PASG↓ Sell$50K
Apr 10, 2025XTNT↓ Sell$30.7M
Apr 9, 2025CMPX↓ Sell$5.7M
Apr 3, 2025EWTX↑ Buy$10.0M
Mar 24, 2025IRON↓ Sell$310K
Mar 21, 2025IRON↓ Sell$2.8M
Mar 12, 2025IRON↓ Sell$17.0M
Feb 18, 2025MBX↑ Buy$2.0M
Feb 10, 2025SION↑ Buy$9.9M
Jan 14, 2025PASG↓ Sell$142K
Jan 8, 2025PASG↓ Sell$103K
Dec 20, 2024PASG↓ Sell$138K
Dec 11, 2024PASG↓ Sell$52K
Dec 6, 2024PASG↓ Sell$77K
Oct 15, 2024UPB↑ Buy$14.0M
Sep 19, 2024PASG↓ Sell$28K
Sep 18, 2024PASG↓ Sell$147K
Sep 16, 2024MBX↑ Buy$8.0M
Sep 16, 2024MBX↑ Buy$4.0M
Aug 26, 2024SPRY↓ Sell$1.1M
Aug 23, 2024SPRY↓ Sell$11.5M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ETRA insiders

Open-market trades in the last 12 months

About Orbimed Advisors LLC's insider trades

Orbimed Advisors LLC is a director at Electra Therapeutics (ETRA). Since Jul 13, 2005, it has reported 161 open-market purchases worth $973.2M and 210 sales worth $1.96B on SEC Form 4. In the last 12 months: 9 buys ($130.7M) and 12 sales ($106.5M).

21 sales (4% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Its filings also include conversions (83 filings), other transactions (42 filings), grants and awards (29 filings), option exercises (20 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ETRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.